Women's Health

Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Fierce Biotech
Bayer
KaNDy Therapeutics
M&A
Women's Health
menopause
hot flashes
NT-814
Flag link:
Olema Oncology grabs $54M for breast cancer program
Olema Oncology grabs $54M for breast cancer program
Fierce Biotech
Olema Oncology
Women's Health
breast cancer
OP-1250
Flag link:
AMAG Pharma Sells Off Women’s Health Product in Planned Divestment
AMAG Pharma Sells Off Women’s Health Product in Planned Divestment
Xconomy
Amag Pharmaceuticals
Women's Health
Millicent Pharma
Flag link:
Is Merck a Better Buy After Announcing Spinoff?
Is Merck a Better Buy After Announcing Spinoff?
Motley Fool
Merck
spinoffs
Women's Health
biosimilars
Flag link:
Merck to spin off new $6.5 billion firm focused on women’s health, older drugs
Merck to spin off new $6.5 billion firm focused on women’s health, older drugs
Stat
Merck
spinoffs
Zetia
Vytorin
Women's Health
Flag link:
[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension
[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension
CP WIre
hypertension
Duke University
Women's Health
SIAM News
Flag link:
[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension
hypertension
Duke University
Women's Health
SIAM News
Flag link:
AHA: Caladrius single injection helps heart disease that hits women the hardest
AHA: Caladrius single injection helps heart disease that hits women the hardest
Fierce Biotech
Caladrius Biosciences
Women's Health
heart disease
AHA
CLBS16
Syndrome X
Flag link:
One health care startup at a time, this venture capitalist wants to harness the investing power of women
One health care startup at a time, this venture capitalist wants to harness the investing power of women
Stat
venture capital
biotech
startups
Women's Health
Flag link:
Biotech startup joins quest to harness microbiome to untether reliance on antibiotics in women's health
Biotech startup joins quest to harness microbiome to untether reliance on antibiotics in women's health
Endpoints
Luca Biologics
microbiome
Women's Health
vaginal microbiome
Flag link:
Apple recently hired a prominent obstetrician, signaling interest in women's health
Apple recently hired a prominent obstetrician, signaling interest in women's health
CNBC
Apple
Women's Health
Flag link:
Evotec and Ferring Team Up to Work on Women's Health Issues
Evotec and Ferring Team Up to Work on Women's Health Issues
CP Wire
Evotec
Ferring
small molecule drugs
Women's Health
Fertility
Flag link:
Allergan plans sales of women's health, infectious disease units
Allergan plans sales of women's health, infectious disease units
Reuters
Allergan
M&A
Women's Health
infectious diseases
Flag link:
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Fierce Pharma
Allergan
Women's Health
M&A
Flag link:
Teva closes $703m sale of global women’s health biz to CVC Capital
Teva closes $703m sale of global women’s health biz to CVC Capital
Drug Delivery Business News
Teva Pharmaceutical
Women's Health
M&A
CVC Capital
Flag link:
Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report
Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report
Endpoints
Women's Health
KaNDy
Allergan
M&A
Flag link:
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Endpoints
Allergan
Repros
M&A
Women's Health
Flag link:
Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS
Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS
Stat
drug pricing
Women's Health
Obamacare
healthcare reform
HHS
Alex Azar
Eli Lilly
Flag link:
Allergan could sell women's health for $6B, if it would only agree to split: analyst
Allergan could sell women's health for $6B, if it would only agree to split: analyst
Fierce Pharma
Allergan
Women's Health
M&A
Flag link:
Cash-strapped Teva closes in on women's health sale No. 2: report
Cash-strapped Teva closes in on women's health sale No. 2: report
Fierce Pharma
Teva Pharmaceutical
Women's Health
M&A
CVC
Flag link:

Pages